Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
My Humble Opinion
|
Other People's Opinion
|
| A "Must Read" Blog for Insiders. -- Wall Street Journal | A bi-weekly podcast. Listen and call-in live online or download to your iPod! |
| Also see Pharma Marketing News OpEd Pieces |
Brave New Pharma?Posted: January 8, 2007Seems I have a lot of questions this month! I mean to say, a lot of my recent posts have questions as titles. Why do I do that? Anyway, this question has to do with the effect -- or lack thereof -- of FDA warning letters on pharmaceutical companies and product managers. The question arose in an offline discussion I recently had with a product manager in response to my recent post entitled "YouPharma(tm): A Brave New World of Marketing?" In that post, I challenged the pharmaceutical industry to engage their customers and consumers through Web 2.0 and other technologies. BTW, if you are interested in this topic, I am doing a live podcast tomorrow at 1 PM Eastern time on that subject (see "Web 2.0 for Pharma Marketing"). I will be interviewing a couple of interesting experts and taking calls from listeners. Hope you listen in. Otherwise, download the audio afterward. I have laid down the gauntlet to product managers and hope they respond by joining the new Forum, "Product Manager Corner," which I established on the Pharma Marketing Network Forums site. There, I ask "Are Product Managers Lemmings or Scaredy Cats?" If you want to respond to that, please join the Forum. You can cloak your identity and post anonymously without moderation. But follow the rules and be polite! If you want to read more about this topic, see today's post to Pharma Marketing Blog. For more posts in related topic areas, see: If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.
|
Special Supplement ePharma Marketing
The selection of articles in this Special Supplement to Pharma Marketing News was chosen to give you a better perspective on pharma eMarketing. Included are real world case studies that illustrate the advantages of eMarketing such as depth of information, interaction, relationship building and superior customer engagement.
Order and pay for this Special Supplement now using your credit card ONLY $29.95
If you wish to pay by check or credit card off-line, please use: Special Supplement Relationship Marketing 
Direct, Targeted, Permission-based Marketing Builds Relationships, Increases ROI and Improves Patient Compliance This collection of Pharma Marketing News articles, blog posts, and survey results provides you with an excellent introduction to the many facets and uses of pharmaceutical relationship marketing. Order and pay for this Special Supplement now using your credit card ONLY $29.95
If you wish to be pay by check or credit card off-line, please use: |
